.
When again the excretion is impaired owing to any renal damage or for any other cause, the drug is more acetylated in the system and this latter derivative being poorly soluble is precipitated in the urinary tract with resultant urinary obstruction and subsequent development of pyelonephritis. Smith et al. (1940) further observe that the crystallization of the acetyl sulphapyridine in the urine may even help in the development of renal calculi. The drug is found to produce a more severe mental and physical depression (Finland et al., 1939) . It should not therefore be given to patients with jaundice, or liver or kidney disease. Another side effect of the drug is the production of intense nausea with vomiting (Anderson and Datta, 1939; Bensley, 1940) . Sulphanilamide also causes nausea and vomiting, but these are seldom found to be severe. In view of all these observations, particularly for the occurrence of renal damage, the treatment with this drug must be regarded as potentially dangerous and must be avoided [Feb., 1941 Whitby (1938) the preparation is almost obsolete. The other compound is less toxic than sulphanilamide, but at the same time less efficacious too. On account of its safety, it may be prescribed in milder streptococcal infections. In severe and urgent cases sulphanilamide (II) is the drug of choice.
The two sodium salt derivatives (VII) and (VIII) are of interest for their enhanced solubility. When an immediate effect is necessary, when it is difficult for the patient to swallow the tablet products, when nausea and vomiting are pronounced, or when the conditions do not allow a proper concentration of the drug in the blood, they may be parenterally used. In cerebrospinal infections the red variety (VII), however, penetrates from the blood to the theca more slowly than sulphanilamide (Jauerneck and Gueffroy, 1937) . Further, in urinary infections the excreted product is only a urinary antiseptic, in so far as the compound has been reduced to colourless sulphanilamide. In these respects, however, the other compound is invariably being found to be clinically more effective in streptococcal and meningococcal infections. It has also been reported to be efficacious in influenzal meningitis (Teggart, 1938 Fleming (1938) , De and Bas (1938) , and Loewenthal (1939) (De and Basil, 1937 
